Related Experiment Videos
Supraventricular tachycardia in an infant
Journal of Emergency Nursing
|December 1, 1992
Insights
Adenosine is highly effective for treating supraventricular tachycardia (SVT) in infants, with no observed side effects. Further research is recommended to confirm its safety and efficacy in pediatric patients.
Area of Science:
- Pediatric Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Supraventricular tachycardia (SVT) is a common cardiac arrhythmia in infants.
- Vagal maneuvers are the first line of treatment for pediatric SVT.
- Adenosine is an antiarrhythmic drug used for SVT in adults.
Observation:
- A 1-month-old infant diagnosed with SVT was treated with adenosine.
- The treatment was administered due to failure of vagal maneuvers.
- The infant's response to adenosine was closely monitored.
Findings:
- Adenosine administration was extremely effective in terminating the infant's SVT.
- No observable adverse side effects were noted in the patient post-administration.
- The infant tolerated the medication well, indicating a positive safety profile in this case.
Implications:
- Adenosine demonstrates significant potential as a safe and effective treatment for infant SVT.
- Emergency nurses should be knowledgeable about adenosine protocols for pediatric SVT.
- Further clinical studies are warranted to establish comprehensive guidelines for adenosine use in pediatric populations.
Abstract:
Treating this 1-month-old infant with SVT with adenosine was extremely effective and resulted in no observable side effects to the patient. More research needs to be performed and documented regarding the effectiveness and safety of this drug in pediatric patients. Emergency nurses should familiarize themselves with adenosine and should suggest its use in pediatric patients with SVT that does not respond to vagal maneuvers.